NCT04261335View on ClinicalTrials.gov

The Clinical Trial of CL2020 Cells for Neonatal Hypoxic Ischemic Encephalopathy

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 4, 2020

Primary Completion Date

September 29, 2021

Study Completion Date

December 12, 2022

Conditions
Hypoxia-Ischemia, Brain
Interventions
BIOLOGICAL

CL2020 cells

1.5 million or 15 million cells, IV on day 5 to 14 of birth

Trial Locations (1)

466-8560

Nagoya University Hospital, Nagoya

Sponsors
All Listed Sponsors
collaborator

Life Science Institute, Inc.

UNKNOWN

lead

Nagoya University

OTHER